Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Content :

Innovating in Rare Diseases

Life is a health journey that for some starts with being born with a rare genetic disorder. There are more than 7,000 rare diseases in the world and 30% of children affected will die before reaching their 5th birthday. Gaucher disease is considered an ultra-rare disease which occurs in approximately 1 in 40,000-60,000 people in the general population, or about 10,000 people globally.

As a health journey partner, Sanofi Genzyme brought to people living with Gaucher disease the first-of-its-kind enzyme replacement therapy given by intravenous infusion to treat this disease in the 1980s. Continuing its commitment to the Gaucher community and through further research and development, Sanofi Genzyme developed an oral therapy for the treatment of certain adults with Gaucher disease type 1, providing another treatment option to support them to continue their lives uninterrupted whilst on treatment.

 

©Oote Boe/Plainpictures

Sanofi, Empowering Life.

 

 

Updated: December 18, 2017